Fairfield, Bush & Co.
- SEC CIK
- 0001116247
- Latest filing
- Aug 13, 2026
LLY holding history
Eli Lilly & Co in every 13F filed by Fairfield, Bush & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LLY overviewAll 13F holders of LLYFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,869
- Value
- $3.44M
- % of portfolio
- 1.7%
- Quarters held
- 20
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,869 | $3.44M | 1.7% | +32+1.1% | Added | Holders |
| Q1 2026 | 2,837 | $2.61M | 1.4% | −4−0.1% | Reduced | Holders |
| Q4 2025 | 2,841 | $3.05M | 1.6% | −115−3.9% | Reduced | Holders |
| Q3 2025 | 2,956 | $2.26M | 1.2% | +131+4.6% | Added | Holders |
| Q2 2025 | 2,825 | $2.20M | 1.2% | +74+2.7% | Added | Holders |
| Q1 2025 | 2,751 | $2.27M | 1.4% | +30+1.1% | Added | Holders |
| Q4 2024 | 2,721 | $2.10M | 1.2% | −5−0.2% | Reduced | Holders |
| Q3 2024 | 2,726 | $2.42M | 1.4% | +425+18.5% | Added | Holders |
| Q2 2024 | 2,301 | $2.08M | 1.2% | +162+7.6% | Added | Holders |
| Q1 2024 | 2,139 | $1.66M | 1.0% | +24+1.1% | Added | Holders |
| Q4 2023 | 2,115 | $1.23M | 0.7% | +194+10.1% | Added | Holders |
| Q3 2023 | 1,921 | $1.03M | 0.7% | −24,555−92.7% | Reduced | Holders |
| Q2 2023 | 26,476 | $12.4M | 3.4% | −231−0.9% | Reduced | Holders |
| Q1 2023 | 26,707 | $9.17M | 3.2% | +25,080+1,541.5% | Added | Holders |
| Q4 2022 | 1,627 | $595.2K | 0.4% | +635+64.0% | Added | Holders |
| Q3 2022 | 992 | $321.0K | 0.2% | +587+144.9% | Added | Holders |
| Q2 2022 | 405 | $131.0K | 0.1% | +405 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −3,000−100.0% | Sold out | Holders |
| Q3 2021 | 3,000 | $693.0K | 0.2% | −21,325−87.7% | Reduced | Holders |
| Q2 2021 | 24,325 | $5.58M | 1.5% | 00.0% | Unchanged | Holders |
| Q1 2021 | 24,325 | $4.54M | 1.3% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.